We develop novel single cell analysis systems for scientists searching for rare and valuable biological variants across research, therapeutic, bioproduction and diagnostic applications. Our flexible technology, innovative products and range of services help you to boost throughput and sensitivity, while reducing costs and saving time.
Dr Marian RehakR&D Director
Dr Robert MarchmontCommercial Director
SYNthesis Research has established a number of R&D collaborations which have generated novel IP which is now available for partnering. SYNthesis Research's sister company, SYNthesis med chem, is a chemistry-focussed contract research organisation that carries out custom synthesis and medicinal chemistry projects.